Ifosfamide, carboplatin, and etoposide in combination for induction and high-dose chemotherapy: focus on breast cancer and lymphoma-Reference-Cited by-同舟云学术

Ifosfamide, carboplatin, and etoposide in combination for induction and high-dose chemotherapy: focus on breast cancer and lymphoma

Published:1992-01 Issue:1 Volume:10 Page:61-74
ISSN:0278-0232
Container-title:Hematological Oncology
language:en
Short-container-title:Hematol. Oncol.

Author:

Fields Karen K.,Elfenbein Gerald J.,Saleh Ramy A.,Zorsky Paul E.,Janssen William E.,Perkins Janelle B.,Saleh Theresa G.,Piazza Joanna T.,Kronish Lori E.,Machak Mary C.,Lyman Gary H.

Publisher

Wiley

Subject

Cancer Research,Oncology,Hematology,General Medicine

Reference27 articles.

1. Advanced Breast Cancer: High-Dose Chemotherapy and Bone Marrow Autotransplants

2. Combination Chemotherapy as an Adjuvant Treatment in Operable Breast Cancer

3. Ifosfamide-pharmacology, safety and therapeutic potential

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy of carboplatin with an MEP (mitoxantrone, etoposide and prednisone) regimen for relapsed and CHOP-resistant diffuse large B-cell lymphomas;Leukemia Research;2002-03

2. Abstracts;Cancer Investigation;1996-01

3. Relative Contributions of Marrow Microenvironment, Growth Factors, and Stem Cells to Hematopoiesis in Vivo in Man.;Annals of the New York Academy of Sciences;1995-12

4. High-dose ifosfamide, carboplatin, and etoposide with autologous stem-cell support.;Journal of Clinical Oncology;1995-07

5. Maximum-tolerated doses of ifosfamide, carboplatin, and etoposide given over 6 days followed by autologous stem-cell rescue: toxicity profile.;Journal of Clinical Oncology;1995-02